Hypoactive Sexual Desire Disorder (HSDD) treatment, diagnosis & prescriptions

Maple is a virtual care platform that connects you with doctors and other healthcare providers via text, audio, or video. After you log in to your Maple account, you can request an online consultation.

Consultations work similarly to in-person appointments — the doctor can complete an assessment by asking questions about your symptoms, going through your health history, and determining what treatment is right for you. If they think your condition is more serious, they may tell you to go to a clinic for an in-person examination.

As a Maple member, you get 24/7 access to virtual primary care online and more. You can connect with our network of providers via text, audio, or video call within minutes.

Our membership costs $79.99/month and covers virtual care for patients and their families, including the primary account holder's spouse and any dependents.

For patients in eligible provinces, our membership includes:

• Access to daily primary care provider visits: One daily visit with a primary care provider for each family member in their household.
• Paediatric care: Covered paediatric primary care visits, available by appointment.
• Second medical opinions: access to a network of experts for a second opinion if diagnosed with a complex condition (e.g. cancer).
• Personal Health Check-Ins: A series of personalized, evidence-based proactive care screenings to maintain and improve health.
• iCBT courses: Access to iCBT (internet-based cognitive behavioural therapy) self-assessment and courses.
• Access to specialists in eligible provinces: Easy access to specialists on Maple within days, not months. No referral is needed.
• Specialist referrals in eligible provinces: Ability to be referred to a physician specialist for in-person care, if needed.
• Credit discounts: An $80 credit per month to be applied to a Maple specialist visit.

Please note that our membership cannot be combined with other offerings, such as private insurance coverage and provincial programs, where available. In some cases, membership fees can be covered by a Healthcare Spending Account (HSA) — check with your HSA provider for more details.

We accept all major credit cards, including AMEX cards, as well as Google and Apple Pay.

At Maple, we proudly prioritize privacy as a cornerstone of our virtual care services. We strictly adhere to privacy and healthcare legislation in Canada, such as PIPEDA and PHIPA regulations, to ensure patients' personal and health information remains completely private and safeguarded.

Our policies and consent processes are designed to be simple and easily understood, empowering individuals with control and a clear understanding of their healthcare journey. When using our services, a patient’s session is protected by a comprehensive security infrastructure and stringent data policies.

Patients also retain full control of their personal health information, medical records and test results at all times. Our approach is reinforced by consultations with leading experts, guaranteeing comprehensive policy frameworks that are reviewed at a regular cadence.

All providers delivering healthcare through Maple are licensed in Canada and governed by their licensing regulatory colleges, and in all instances, must act in accordance with the governing principles set out in the telemedicine policies of each medical regulator in the applicable province.

Regulators across Canada support and recognize the value of services like ours, and the way in which they can benefit patients, physicians, and Canada’s broader healthcare system by improving access to care and increasing efficiencies in the delivery of care.

Did you know that a decrease in sexual desire is the most common sexual complaint for women in North America?

Approximately 1 in 10 women experience a distressing loss of sexual desire. It is often persistent and does not change regardless of how much they love their partner or what sexual stimulus they receive. These women may suffer from a medical condition known as Hypoactive Sexual Desire Disorder, or HSDD, also sometimes called hyposexual desire disorder or low sexual desire disorder.

Learn more about HSDD here.

An estimated 38.7% of women experience a lack of sexual desire. HSDD — a persistent and distressing loss of sexual desire — affects about 10% of the population (over 15 million women in North America!)

Symptoms of hypoactive sexual desire disorder include:

• Persistent, recurrent deficiency of sexual desire
• Absence of sexual fantasies and desire for sexual activity
• Marked distress or interpersonal difficulty not better accounted for by another sexual dysfunction disorder and not due exclusively to the direct effects of a medication or a medical condition

The treatment of HSDD starts with a visit to a licensed and sympathetic physician. If you are a woman diagnosed with HSDD or low sexual desire, your doctor might discuss several options with you.

Counseling/Sex Therapy – Desire for sex can be dependent upon a number of factors beyond biology, such as issues around intimacy, physical health, and cultural norms. These treatment options can provide guidance to partners with sexual incompatibilities or sexual dysfunction. It may focus on teaching patients about the body and sex, or how sexuality changes as we age.

Medication – Your doctor may consider a number of options depending on your condition. In Canada, there is currently one drug that is approved for use in premenopausal women with acquired, generalized HSDD. A prescription for this drug may be considered by your doctor if your low sexual desire has persisted for a minimum of six months, occurs 75-100% of the time, and is causing marked distress or interpersonal difficulty.

Yes, absolutely. Maple doctors are trained to diagnose, treat, and prescribe for sexual health conditions on Maple. The doctor will discuss options for treatment during an online consultation. They will assess if you have any co-existing medical or psychiatric conditions and determine potential effects of medications or other drug substances to determine the best course of treatment.